A new pancreatic cancer trial that aims to match patients with more targeted and effective treatment for their tumours is to begin in Glasgow.

Precision-Panc, a research programme and clinical trials project, has been given approval by NHS Greater Glasgow and Clyde to begin recruiting patients for trials.

Eligible patients will undergo a tumour biopsy to obtain material that will then be used for molecular profiling at the Glasgow precision oncology laboratory

The results will then be used to help match patients to the most appropriate currently available clinical trial.

Led by Glasgow University, the project is majority-funded by Cancer Research UK.

Director of operations at Pancreatic Cancer UK, Anna Jewell said: "It's incredibly exciting to see the first stages of this game-changing effort to change the future for people with pancreatic cancer.

"The clinical trial in Glasgow will provide a much-needed new treatment option for eligible patients with a disease which sadly has so few treatments available, and we would encourage patients to ask their doctor or consultant if they think this trial would be suitable for them."

She added: "The overall aim of Precision-Panc is to make precision medicine a reality for more people with pancreatic cancer through building up knowledge that will ultimately allow clinicians to match patients with the most suitable treatment or clinical trial for them.

"We are proud to be a part of this vitally important work for everyone affected by this tough disease."